...
首页> 外文期刊>Internal medicine. >Successful Treatment of Rapidly Progressive Unclassifiable Idiopathic Interstitial Pneumonia with Anti-melanoma Differentiation-associated Gene-5 Antibody by Intensive Immunosuppressive Therapy
【24h】

Successful Treatment of Rapidly Progressive Unclassifiable Idiopathic Interstitial Pneumonia with Anti-melanoma Differentiation-associated Gene-5 Antibody by Intensive Immunosuppressive Therapy

机译:强化免疫抑制疗法成功治疗抗黑素瘤分化相关基因5抗体快速进展的无法分类的特发性间质性肺炎

获取原文
   

获取外文期刊封面封底 >>

       

摘要

We describe a case of a woman who presented with a persistent cough, general fatigue, and a fever. Interstitial lung disease was rapidly progressive and resistant to high-dose steroid therapy. She tested positive for the presence of anti-melanoma differentiation-associated gene 5 (MDA-5) antibody, although she had no skin manifestations of dermatomyositis. She was eventually diagnosed with unclassifiable idiopathic interstitial pneumonia and was successfully treated with intensive immunosuppressive therapy including intravenous cyclophosphamide. To our knowledge, this is the first report of anti-MDA-5 antibody in a patient with idiopathic interstitial pneumonia.
机译:我们描述了一例持续咳嗽,全身乏力和发烧的女性。间质性肺疾病进展迅速,对大剂量类固醇疗法有抵抗力。尽管她没有皮肌炎的皮肤表现,但她检测出抗黑素瘤分化相关基因5(MDA-5)抗体呈阳性。最终她被诊断出患有无法分类的特发性间质性肺炎,并成功通过强化免疫抑制疗法(包括静脉内环磷酰胺)进行了治疗。据我们所知,这是特发性间质性肺炎患者抗MDA-5抗体的首次报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号